14th February, 2022.
Right … I’m officially up earlier than normal: and thinking a dose of the ’flu — or whatever it is I actually have — doesn’t help!
But … ?
My nephew heading over early, today, means I’m up early, my self.
Do you get the feeling there’s going to be slightly grumpy video making, today?
Oy … !
~≈§≈~
Of course, I’ve got the radio on.
Or, at least, got Radio Four’s Today programme on.
Something that caught my (metaphorical) eye? Or ear, at least?
Was a piece that told us AstraZeneca and the UK’s medical regulators have withdrawn approval for the 5ml dosage of a drug called Dapagliflozin — brand name, Forxiga — for patients with type one diabetes.
Or, at least, withdrawn the indication for it to be used. I’m assuming that’s functionally identical with ‘withdrawing approval.’
Apparently?
There’s no safety concerns involved.
And those of us — like me — who are taking Forxiga to treat Type Two diabetes should continue taking it.
Quite what’s going on there … ?
I don’t know.
~≈§≈~
